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Editorial on the Research Topic
Neuro-Immune Interactions in Inflammation and Autoimmunity
The nervous system plays an important role in the regulation of immunity and inflammation 
(1, 2). However, neuronal integrity and brain function may be severely altered in inflammatory and 
autoimmune conditions (3–5). Recent studies have characterized neural pathways communicating 
peripheral inflammatory signals to the central nervous system (CNS), and brain- and spinal cord-
derived circuitries controlling various innate and adaptive immune responses and inflammation 
(1, 2). A prototypical neural reflex circuit that regulates immunity and inflammation is the vagus 
nerve-based “inflammatory reflex” (6). Pharmacological and bioelectronic modulation of neural 
cholinergic circuitry in the inflammatory reflex has been successfully explored in preclinical set-
tings of sepsis, arthritis, inflammatory bowel disease, obesity-driven disorders, diabetes, and other 
diseases (1). These studies paved the way to successful clinical trials in inflammatory bowel disease, 
rheumatoid arthritis, and metabolic syndrome (7–9).
Dysregulated release of cytokines and other inflammatory molecules may have a severe impact on 
brain function (10). Brain inflammation (neuroinflammation), imbalances in brain neuronal integ-
rity, neurotransmitter release, and cognitive impairment are characteristic features of perioperative 
neurological disorders, sepsis, pain, liver diseases, diabetes, and other conditions characterized by 
immune and metabolic dysregulation (3, 11, 12). These findings and the characterization of brain-
reactive antibodies and neuroprotective cytokines indicated new therapeutic approaches for treating 
inflammatory and autoimmune disorders and their neurological complications (4, 13, 14).
The collection of 19 papers on this research topic substantially contributes to improved under-
standing of neuro-immune communication and its therapeutic relevance. Yuki et al. elaborate on 
neuro-immune interactions within the gateway reflexes that regulate the entry of pathogenic CD4+ 
T lymphocytes in the CNS and neuroinflammation. They also point to the need of further charac-
terization of the functional anatomy of these reflexes that will be of interest for their therapeutic 
exploration to alleviate local neuroinflammation in pathological conditions, including multiple 
sclerosis. Bonaz et al. review the role of the vagus nerve as a regulator of inflammatory processes 
in the gastrointestinal tract. They also elaborate on accumulating experimental evidence indicating 
possibilities to use electrical vagus nerve stimulation for therapeutic benefit in inflammatory bowel 
disease and other gastrointestinal disorders in preclinical and clinical settings. Innoe et al. outline new 
findings related to the neural vagus nerve control of inflammation with a specific focus on the kidney 
disease. They also summarize evidence that this neural regulation can be activated by the use of ultra-
sound and other modalities to alleviate inflammation and acute kidney injury in murine models. The 
splenic noradrenergic innervations are implicated in neuroimmunomodulation and are an important 
component of the inflammatory reflex through their functional cooperation with the vagus nerve. 
Hoover et al. provide insight into the anatomy of noradrenergic neurons in relation to leukocytes in 
the human spleen and experimental evidence for a significant splenic noradrenergic neuronal loss 
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in patients who died from sepsis. These findings are of interest 
for further studies on the neural regulation of inflammatory pro-
cesses in the spleen in the context of sepsis and other conditions. 
Fujii et al.  present a thorough review of the cholinergic system, 
including choline acetyltransferase, acetylcholinesterase, acetyl-
choline, and muscarinic and nicotinic acetylcholine receptors in 
immune cells, such as macrophages, dendritic cells, and T and B 
lymphocytes. They also summarize findings about the functional 
role of this non-neuronal cholinergic system in the regulation of 
innate and adaptive immune responses. Valdés-Ferrer et al. evalu-
ated the role of pyridostigmine, an acetyl-cholinesterase inhibitor, 
in a 16-week proof-of-concept open-label trial in HIV-infected 
patients with discordant immune responses. By using this strategy, 
the authors harnessed the cholinergic anti-inflammatory pathway 
and demonstrated that pyridostigmine can promote recovery of 
CD4+ T-cell counts by reducing T cell overactivation. Bosmans 
et al. discuss the role of cholinergic signaling, mediated through 
nicotinic and muscarinic receptors in the regulation of allergic 
inflammation, including barrier function, innate and adaptive 
immune responses, and effector cells responses. They also point to 
possibilities of exploring cholinergic regulation of type 2 immune 
responses in the treatment of allergic diseases.
Mader et al. outline how antibodies associated with autoim-
mune diseases lead to brain pathology and irreversible damage, 
specifically focusing on conditions such as systemic lupus erythe-
matosus and neuromyelitis optica. They summarize some of the 
key mechanisms involved in these antibody-mediated patholo-
gies and discuss the urgency to develop more appropriate and less 
invasive treatments for antibody-mediated diseases. Foster et al. 
outline the latest insights into the molecular mechanisms of the 
relationship between sensory neurons and immune cells, which 
can be protective, but also maladaptive. They elaborate on the 
role of nociceptors (noxious stimulus detecting sensory neurons) 
in the regulation of adaptive immunity with a specific focus on 
the involvement of nociceptors in the regulation of type 2 adap-
tive immune responses in airway inflammation. Gunasekaran 
et al. report on their discovery that peripheral sensory neurons 
of the dorsal root ganglia (DRG) of immunized mice contain 
antigen-specific antibodies. The authors use a combination 
of molecular genetic analyses, transgenic mice, and adoptive 
transfer experiments, to reveal that DRGs do not synthesize 
antigen-specific antibodies, but sequester primarily IgG1 subtype 
antibodies released by antibody-secreting plasma cells. In the 
broader context of the role of DRG sensory neurons in regulating 
antigen trafficking during immunization, these findings suggest 
that the nervous system may cooperate with the immune system 
to regulate antigen-mediated responses. Maurer and Williams 
describe the role of cholinergic signaling in cognition from the 
perspective of cholinergic modulation of microglia and astrocyte 
function, and the role of this regulation in Alzheimer’s disease 
and Parkinson’s disease. The colleagues focus on the cholinergic 
modulation of hippocampus-related neuroplasticity and memory 
processes and the involvement of the α7 nicotinic acetylcholine 
receptor in neuro-immune regulation in this context. Zaghloul 
et al. present new data about forebrain cholinergic dysfunction 
in parallel with neuroinflammation and peripheral immune 
and metabolic dysregulation in mice  surviving cecal ligation 
and puncture-induced sepsis. These findings suggest that brain 
cholinergic signaling can be further explored as a therapeutic 
target in chronic sepsis illness, including cognitive impairment, 
functional disabilities, and alarmingly high mortality. Feng et al. 
demonstrate that preoperative exercise prevents the cognitive 
decline and neuroinflammation and increases the diversity of 
the gut microbiome in a model of tibia fracture with internal 
fixation surgery in rats with metabolic syndrome. These findings 
are of interest for considering exercising, acting as a microbiome 
modulator, in alleviating persistent cognitive impairment and 
neuroinflammation in postoperative conditions in high risk set-
tings. Yang et al. used a laparotomy model in mice to report on 
the role of the blood–brain barrier in postoperative cognitive dys-
function. They found that anesthesia/surgery triggers endothelial 
dysfunction in an interleukin-6-dependent and age-associated 
manner, with significant cognitive impairments evident in 18-, 
but not 9-month-old mice. These data offer additional insights 
into the pathogenesis of postoperative complications like delir-
ium and postoperative cognitive  dysfunction. Berger et al. report 
results from a clinical study designed to evaluate neuroinflam-
mation in patients with intracranial surgery receiving anesthetic 
maintenance with propofol or isoflurane. They found significant 
increases in cerebrospinal fluid (CSF) cytokine levels 24 h after 
surgery (as compared with levels before surgery), in parallel with 
increased CSF levels of tau, a neural injury biomarker, but no sig-
nificant differences in terms of the anesthetic used. These results 
suggest that postoperative neuroinflammation in two anesthesia 
regimens may have a role in neural injury following intracranial 
surgery. Zhang et al. describe the neuroprotective effects of an 
annexin A1-derived small peptide on postoperative inflamma-
tion and cognitive function after cardiac surgery in rats. They 
report significant attenuation of microglial activation, cell death 
 markers, and NF-κB activation after cardiopulmonary bypass 
with deep hypothermic circulatory arrest and, in  vitro, using 
oxygen-glucose deprivation. These results provide evidence for 
the use of novel resolution agonists to treat inflammatory condi-
tions in the perioperative space. Whittington et al. review the role 
of inflammation and specialized pro-resolving lipid mediators in 
neurological conditions and Alzheimer’s disease. Resolution of 
inflammation is well appreciated as an active process regulated by 
specialized pro-resolving lipid mediators derived from omega-3 
fatty acids. The authors discuss on both preclinical and clinical 
evidence supporting the hypothesis that Alzheimer’s disease is a 
neurodegenerative disorder where failed resolution contributes 
to the disease process. Huh et al. outline the role of bone marrow 
stem cells or bone marrow stromal cells (BMSCs) in modulat-
ing chronic pain by acting in a paracrine fashion on peripheral 
and CNS sites to regulate inflammation. The authors review the 
mechanisms of substantial anti-nociceptive efficacy of BMSCs 
in preclinical and clinical settings and suggest possibilities for 
their use in the management of chronic pain. Pittaluga reviews 
the brain functional cross-talk between CCL5 (RANTES), 
released from glial cells and glutamate, the main excitatory 
neurotransmitter in the brain, in physiological and pathological 
conditions. She focuses on preclinical data demonstrating the 
role of CCL5 as a modulator of glutamatergic transmission in 
health and in demyelinating diseases with relevance to the onset 
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of psychiatric symptoms and the progression of inflammation 
and demyelination.
Overall, the content of this research topic reflects the signifi-
cant growth and advances in the field of neuro-immune interac-
tions. It contributes to improved mechanistic  understanding, 
which is interrelated with evaluating both pharmacological and 
bioelectronic approaches to modulate neural circuitry for thera-
peutic benefit preclinically and in human clinical  trials. Further 
characterization of neural circuits and signaling mechanisms will 
be instrumental to inform the development of safer and more 
efficient therapeutic approaches for diseases characterized by dys-
regulated immune responses,  autoimmunity, and inflammation.
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